20
Participants
Start Date
May 5, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
brimonidine topical gel 0.33% & survey
The internet survey will ask them how often they have used their medication that week, as well as giving them treatment tips and reminders about rosacea triggers. They will be asked a variety of questions during the weekly internet survey- such as the amount of erythema they currently have (measured by VAS scale), how much burning and stinging they have, how often they have used the medication and where did they apply the medication, as well as any additional side effects they may be having from the medication.
brimonidine topical gel 0.33% & SOC
All subjects will receive standard-of-care brimonidine topical gel 0.33%
Dept of Dermatology, WFUHS, Winston-Salem
Wake Forest University Health Sciences
OTHER